BRD2 bromodomain-mediated regulation of cell state plasticity modulates therapy response in glioblastoma
Neuro-Oncology · 2025
DOI: 10.1093/neuonc/noaf169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Raghavendra Vadla und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Regenerative Medicine, Department of Medicine, University of California San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Protein Serine-Threonine Kinases, Cell Plasticity. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Background
Glioblastoma (GBM) displays remarkable cell state plasticity, a major contributor to therapeutic resistance and tumor progression. While epigenetic mechanisms play a central role in driving this plasticity, the key regulators remain poorly understood, and developing effective therapeutic strategies targeting them has been challenging.
Methods
We investigated the role of BRD2, a key regulator of NF-κB-mediated mesenchymal (MES) transition, using GBM patient-derived xenograft cell lines, CRISPR-mediated knock-in/knockout approaches, RNA-seq, and in vitro and in vivo modeling. BET inhibitors were employed to target MES gene expression and sensitize GBM to radiation therapy.
Results
We found that PTEN loss induces RelA chromatin localization and acetylation-mediated recruitment of BRD2 to the MES gene promoters. BRD2 binding is essential for maintaining MES gene expression and phenotype. Genetic ablation or loss-of-function mutation of BRD2 bromodomains reverses MES transition, enhances radiation sensitivity, and improves survival in orthotopic xenograft models. Additionally, treatment with a brain-penetrant BD2-selective inhibitor suppresses the MES phenotype and increases radiation sensitivity of GBM stem cells in vitro.
Conclusion
Our study identifies BRD2 as a key mediator of MES transition in GBM, with its bromodomains playing a crucial role in driving cell state plasticity. Targeting BRD2 with BD2-selective inhibitors offers a promising therapeutic strategy to overcome radiation resistance and improve outcomes for GBM patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Regenerative Medicine, Department of Medicine, University of California San Diego, La Jolla, California, USA.
- Medical Scientist Training Program, University of California, San Diego, La Jolla, California, USA.
- Medical Scientist Training Program, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Pathology, Division of Neuropathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Bioengineering, University of California, San Diego, La Jolla, California, USA.
- Departments of Molecular and Medical Pharmacology, University of California, Los Angeles, California, USA.
ORCID-Profile: Raghavendra Vadla, Frank B Furnari
Förderung
- NIH HHS
- NCI NIH HHS
- NINDS NIH HHS
- NIH
Zitieren
APA
Vadla, R., Taylor, B., Miyake, Y., Lin, B., Kawauchi, D., Miki, S., Nathwani, N., Jones, B. M., Kaur, Y., Banerjee, A., Pham, P., Tsang, J., Baldwin, A., Nathanson, D. A., Pizzo, D. P., Miller, C. R., & Furnari, F. B. (2025). BRD2 bromodomain-mediated regulation of cell state plasticity modulates therapy response in glioblastoma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf169
Vancouver
Vadla R, Taylor B, Miyake Y, Lin B, Kawauchi D, Miki S, et al. BRD2 bromodomain-mediated regulation of cell state plasticity modulates therapy response in glioblastoma. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf169
BibTeX
@article{Vadla2025,
author = {Vadla, Raghavendra and Taylor, Brett and Miyake, Yohei and Lin, Benjamin and Kawauchi, Daisuke and Miki, Shunichiro and Nathwani, Nidhi and Jones, Brandon M and Kaur, Yashpreet and Banerjee, Abhinaba and Pham, Philip and Tsang, Jonathan and Baldwin, Albert and Nathanson, David A and Pizzo, Donald P and Miller, C Ryan and Furnari, Frank B},
title = {BRD2 bromodomain-mediated regulation of cell state plasticity modulates therapy response in glioblastoma},
journal = {Neuro-Oncology},
year = {2025},
doi = {10.1093/neuonc/noaf169}
}
EUVIMED